Hint mode is switched on Switch off

Certara, ordinary share
CERT, US15687V1098

Add a stock to WL
Choose all Reset all
Certara, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Certara Inc provides drug development software and services. The Company offers drug development and clinical pharmacology strategy, regulatory strategy, writing and submission, as well as HEOR & market access solutions. Certara serves biopharmaceutical and medical technology ...
Certara Inc provides drug development software and services. The Company offers drug development and clinical pharmacology strategy, regulatory strategy, writing and submission, as well as HEOR & market access solutions. Certara serves biopharmaceutical and medical technology customers worldwide.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Certara Inc
  • Industry
    IT Services and Computer Programming

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERT
  • Placement
    11.12.2020
  • Lock up period
    180
  • Number of papers
    29,055,000
  • Volume of raised funds
    668.27 mln USD
  • Placement share
    18.99%
  • Final placement price
    23 USD
  • Price change since placement date
    -76.98%
  • By capitalization
    3,518.53 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    CERT
  • Placement
    09.09.2021
  • Lock up period
    180
  • Number of papers
    20,000,000
  • Volume of raised funds
    620 mln USD
  • Placement share
    12.71%
  • Final placement price
    31 USD
  • Price change since placement date
    -82.92%
  • By capitalization
    4,878.31 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

12/05/2026 Market Declines: Geopolitical Tensions, Earnings Reports, and ETF Movements Drive Top Losers
11/05/2026 Certara: Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
22/04/2026 Certara: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
27/03/2026 Certara: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
27/02/2026 Certara Inc. (NASDAQ:CERT) Maintains "Outperform" Rating by Leerink Partners
All organization news

Holders

Industry Leaders

Registration is required to get access.